Sodium channel inhibitor Riluzole, Purity ≥98%

Cat. No.: X24-07-ZQ305

Sodium channel inhibitor Riluzole, Purity ≥98%

Synonym: 1744-22-5; Sodium channel inhibitor; PK-26124; RP-54274; Rilutek

  • MDL: MFCD00210213
  • CAS Number: 1744-22-5
  • Compound CID: 5070
Product Size
50 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Riluzole, soluble in DMSO and ethanol and insoluble in water, blocks sodium channels, affecting the action potential propagation in neurons and muscle cells, crucial for neurological and muscular function. It targets glutamate release, NMDA receptor, and sodium channel.
Molecular Weight
234.2
Molecular Formula
C8H5F3N2OS
Targets
Glutamate release; nMDA receptor; Sodium channel
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 42 mg/mL (179.33 mM); Water: Insoluble; Ethanol: 42 mg/mL (179.33 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Riluzole serves as a sodium channel inhibitor, frequently employed in research focused on neuroprotective effects in studies related to amyotrophic lateral sclerosis (ALS) and other neurological disorders.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0